Index RUT P/E - EPS (ttm) -0.80 Insider Own 3.17% Shs Outstand 47.53M Perf Week -9.84%
Market Cap 1.01B Forward P/E - EPS next Y -0.62 Insider Trans -0.94% Shs Float 46.85M Perf Month -20.11%
Income -37.23M PEG - EPS next Q -0.17 Inst Own 98.67% Short Float 6.83% Perf Quarter -37.27%
Sales 414.60M P/S 2.44 EPS this Y -17.88% Inst Trans -1.47% Short Ratio 4.09 Perf Half Y -40.33%
Book/sh 9.43 P/B 2.21 EPS next Y 19.76% ROA -6.34% Short Interest 3.20M Perf Year -56.78%
Cash/sh 2.19 P/C 9.54 EPS next 5Y 20.00% ROE -8.17% 52W Range 20.19 - 59.61 Perf YTD -41.47%
Dividend Est. - P/FCF - EPS past 5Y -1.17% ROI -7.04% 52W High -64.96% Beta 1.45
Dividend TTM - Quick Ratio 2.83 Sales past 5Y 15.61% Gross Margin 74.73% 52W Low 3.47% ATR (14) 1.52
Dividend Ex-Date - Current Ratio 4.00 EPS Y/Y TTM 2.84% Oper. Margin -7.67% RSI (14) 29.48 Volatility 9.42% 5.35%
Employees 1200 Debt/Eq 0.17 Sales Y/Y TTM 18.70% Profit Margin -8.98% Recom 1.00 Target Price 47.33
Option/Short Yes / Yes LT Debt/Eq 0.16 EPS Q/Q -102.14% Payout - Rel Volume 1.23 Prev Close 22.22
Sales Surprise 1.87% EPS Surprise -22.06% Sales Q/Q 16.43% Earnings May 01 AMC Avg Volume 783.10K Price 20.89
SMA20 -13.13% SMA50 -28.30% SMA200 -44.22% Trades
Volume 961,812 Change -5.99%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-23-24 Upgrade Oppenheimer
Perform → Outperform
$32
Oct-23-23 Initiated JMP Securities
Mkt Outperform
$60
Sep-29-23 Initiated UBS
Buy
$56
Aug-05-21 Downgrade Oppenheimer
Outperform → Perform
Dec-18-20 Reiterated Needham
Buy
$53 → $63
Nov-06-20 Reiterated Needham
Buy
$63 → $53
Apr-07-20 Initiated Oppenheimer
Outperform
$45
Feb-06-20 Initiated BTIG Research
Buy
$42
Jan-24-20 Reiterated Needham
Buy
$39 → $48
Aug-13-19 Downgrade Northland Capital
Outperform → Market Perform
$30
Apr-12-19 Initiated JP Morgan
Overweight
$37
Oct-04-18 Reiterated Needham
Buy
$36 → $39
Aug-02-18 Reiterated Stifel
Buy
$32 → $34
Aug-02-18 Reiterated Needham
Buy
$32 → $36
Jun-18-18 Reiterated Needham
Buy
$26 → $32
Apr-27-18 Reiterated Needham
Buy
$23 → $26
Jan-16-18 Reiterated Needham
Buy
$25 → $23
Nov-02-17 Reiterated Needham
Buy
$26 → $25
Jul-28-17 Reiterated Needham
Buy
$25 → $26
May-30-17 Resumed Piper Jaffray
Overweight
Show Previous Ratings
May-02-24 03:18PM
08:36AM
03:49AM
May-01-24 08:57PM
08:00PM
05:55PM
Loading…
05:55PM
05:30PM
04:34PM
(Associated Press Finance)
04:01PM
Apr-30-24 08:00AM
Apr-23-24 07:07AM
Apr-19-24 09:45AM
Apr-18-24 08:00AM
Apr-10-24 08:00AM
Mar-26-24 08:00AM
06:40AM
Loading…
Mar-22-24 06:40AM
Mar-07-24 09:01AM
Feb-28-24 12:47AM
Feb-16-24 11:30AM
09:24AM
(Thomson Reuters StreetEvents)
Feb-15-24 07:00PM
05:10PM
04:44PM
04:15PM
(Associated Press Finance)
04:01PM
Feb-12-24 09:16AM
Jan-25-24 08:00AM
Jan-08-24 08:00AM
Jan-04-24 08:00AM
Dec-20-23 08:00AM
09:55AM
Loading…
Nov-15-23 09:55AM
08:00AM
Nov-14-23 08:00AM
Nov-06-23 12:00PM
Nov-02-23 03:14PM
09:23AM
(Thomson Reuters StreetEvents)
Nov-01-23 06:22PM
06:00PM
04:19PM
(Associated Press Finance)
04:01PM
Oct-31-23 08:00AM
Oct-11-23 08:00AM
Sep-29-23 09:40AM
Sep-11-23 11:45AM
Sep-09-23 07:32PM
Jul-29-23 01:10AM
Jul-27-23 08:50AM
Jul-26-23 07:49AM
(Thomson Reuters StreetEvents) +8.54%
Jul-25-23 08:00PM
05:15PM
04:11PM
04:01PM
Jul-21-23 08:00AM
Jul-03-23 08:00AM
May-25-23 04:02AM
May-04-23 06:21AM
May-03-23 10:50AM
(Thomson Reuters StreetEvents) +9.99%
May-02-23 05:25PM
04:21PM
04:01PM
Apr-19-23 08:00AM
Apr-17-23 10:42AM
Apr-11-23 08:00AM
Apr-03-23 08:00AM
Apr-01-23 09:41PM
Mar-27-23 08:29AM
Mar-18-23 09:14AM
Feb-25-23 02:14PM
Feb-21-23 05:15PM
04:14PM
04:00PM
Feb-17-23 08:00AM
Jan-31-23 08:00AM
Jan-24-23 08:00AM
Jan-09-23 08:00AM
Dec-31-22 08:07AM
Dec-20-22 08:00AM
Dec-08-22 10:30AM
Dec-04-22 07:20AM
Nov-08-22 08:00AM
Nov-01-22 05:55PM
04:01PM
Oct-26-22 10:01AM
Oct-25-22 10:01AM
08:00AM
Oct-11-22 08:00AM
Oct-09-22 08:53AM
Sep-06-22 08:00AM
Aug-16-22 08:00AM
Aug-02-22 05:15PM
04:00PM
06:04AM
Jul-28-22 09:44AM
Jul-20-22 08:00AM
Jul-12-22 08:00AM
Jul-06-22 07:09PM
(American City Business Journals)
Jun-18-22 09:31AM
Jun-07-22 08:00AM
Jun-01-22 01:16PM
(American City Business Journals)
08:00AM
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Noznesky Justin J Chief Mktg & Strategy Officer May 01 '24 Sale 24.09 1,500 36,135 71,284 May 03 08:51 AM Noznesky Justin J Chief Mktg & Strategy Officer Apr 01 '24 Sale 30.39 1,500 45,585 72,784 Apr 03 08:41 AM Dahlquist Karl S. Chief Legal Officer Mar 18 '24 Sale 32.16 1,885 60,622 50,954 Mar 20 08:41 AM Noznesky Justin J Chief Mktg & Strategy Officer Mar 12 '24 Sale 36.72 1,500 55,080 74,284 Mar 14 08:55 AM Dahlquist Karl S. Chief Legal Officer Mar 05 '24 Sale 37.36 8,231 307,510 52,839 Mar 07 07:28 AM Wirick Angela L Chief Financial Officer Mar 01 '24 Option Exercise 16.95 5,000 84,750 139,070 Mar 05 04:46 PM WHITE ROBERT S. Director Feb 23 '24 Option Exercise 15.96 10,000 159,600 88,985 Feb 27 09:00 AM Dahlquist Karl S. Chief Legal Officer Nov 01 '23 Sale 34.43 1,248 42,969 30,789 Nov 03 08:40 AM Dahlquist Karl S. Chief Legal Officer Jul 26 '23 Sale 57.09 3,417 195,077 32,037 Jul 28 08:39 AM Prange Karen Director Jun 08 '23 Sale 47.89 713 34,146 16,140 Jun 12 08:59 AM Dahlquist Karl S. Chief Legal Officer Jun 06 '23 Sale 47.03 1,422 66,877 34,897 Jun 07 08:43 AM Yuen Maggie Director May 26 '23 Sale 47.04 4,313 202,884 4,682 May 30 04:05 PM
Index RUT P/E - EPS (ttm) -5.57 Insider Own 32.72% Shs Outstand 29.65M Perf Week 6.97%
Market Cap 640.27M Forward P/E - EPS next Y -0.85 Insider Trans -0.30% Shs Float 19.49M Perf Month 1.37%
Income -165.95M PEG - EPS next Q -0.30 Inst Own 48.48% Short Float 3.21% Perf Quarter -12.78%
Sales 287.53M P/S 2.23 EPS this Y -123.50% Inst Trans 1.30% Short Ratio 2.87 Perf Half Y -9.47%
Book/sh 37.80 P/B 0.57 EPS next Y 6.86% ROA -12.73% Short Interest 0.63M Perf Year -26.70%
Cash/sh 10.26 P/C 2.09 EPS next 5Y - ROE -13.86% 52W Range 19.88 - 44.09 Perf YTD -25.63%
Dividend Est. - P/FCF 35.67 EPS past 5Y -78.39% ROI -14.57% 52W High -51.24% Beta 1.41
Dividend TTM - Quick Ratio 5.09 Sales past 5Y 258.65% Gross Margin 34.74% 52W Low 8.15% ATR (14) 0.68
Dividend Ex-Date - Current Ratio 5.09 EPS Y/Y TTM -219.30% Oper. Margin -26.03% RSI (14) 55.20 Volatility 4.29% 2.94%
Employees 1184 Debt/Eq 0.01 Sales Y/Y TTM -21.20% Profit Margin -57.71% Recom 2.67 Target Price 26.67
Option/Short Yes / Yes LT Debt/Eq 0.01 EPS Q/Q 12.94% Payout - Rel Volume 1.63 Prev Close 21.24
Sales Surprise -1.34% EPS Surprise 96.86% Sales Q/Q -2.54% Earnings May 03 BMO Avg Volume 217.77K Price 21.50
SMA20 3.77% SMA50 -1.68% SMA200 -20.87% Trades
Volume 355,657 Change 1.22%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-07-23 Initiated UBS
Neutral
$35
Dec-08-22 Downgrade Piper Sandler
Overweight → Neutral
$65 → $40
Nov-18-22 Initiated Raymond James
Outperform
$45
Aug-25-22 Initiated Credit Suisse
Outperform
$65
Feb-04-22 Resumed Piper Sandler
Overweight
$80
Aug-05-21 Resumed Credit Suisse
Underperform
$55
Jan-08-21 Downgrade Credit Suisse
Neutral → Underperform
$42 → $40
Nov-24-20 Downgrade BTIG Research
Buy → Neutral
Aug-20-20 Initiated Oppenheimer
Outperform
$75
May-29-20 Initiated BTIG Research
Buy
$20
Nov-05-19 Upgrade Piper Jaffray
Neutral → Overweight
Mar-01-18 Downgrade Piper Jaffray
Overweight → Neutral
Nov-07-17 Downgrade Raymond James
Outperform → Mkt Perform
Show Previous Ratings
May-04-24 09:15AM
03:04AM
May-03-24 10:46PM
(Thomson Reuters StreetEvents)
11:53AM
08:34AM
08:15AM
Loading…
08:15AM
07:00AM
Apr-11-24 04:05PM
Feb-29-24 09:31AM
Feb-28-24 10:18PM
(Thomson Reuters StreetEvents) -8.14%
07:35AM
07:00AM
Feb-13-24 08:00AM
Feb-09-24 08:31AM
Nov-25-23 09:45AM
04:30PM
Loading…
Nov-14-23 04:30PM
Nov-05-23 09:02AM
Nov-03-23 10:26PM
(Thomson Reuters StreetEvents) +13.24%
04:05PM
08:52AM
08:45AM
07:00AM
Oct-30-23 03:46PM
Oct-25-23 08:00AM
Oct-18-23 09:44AM
Oct-17-23 08:00AM
Aug-05-23 08:56AM
Aug-04-23 10:08PM
(Thomson Reuters StreetEvents)
08:15AM
07:00AM
04:05PM
Loading…
Jul-24-23 04:05PM
Jul-18-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 11:40AM
Jun-06-23 07:45AM
Jun-05-23 08:30AM
May-23-23 09:53AM
08:20AM
May-18-23 04:05PM
May-08-23 11:15AM
09:40AM
May-05-23 08:15AM
07:00AM
Apr-26-23 08:00PM
Apr-20-23 04:05PM
Apr-16-23 02:01PM
Apr-14-23 07:13AM
06:49AM
Apr-12-23 09:40AM
Apr-11-23 08:00AM
Mar-27-23 09:40AM
Mar-24-23 03:54PM
Mar-09-23 09:40AM
Mar-04-23 07:50AM
Mar-03-23 11:17AM
Mar-01-23 10:13AM
(Thomson Reuters StreetEvents)
Feb-28-23 08:25PM
04:05PM
04:03PM
Feb-26-23 09:05AM
Feb-23-23 04:05PM
Feb-14-23 04:05PM
Feb-03-23 05:18AM
Jan-03-23 04:05PM
Dec-15-22 08:11AM
Dec-02-22 12:08PM
Nov-24-22 10:30AM
Nov-17-22 04:05PM
Nov-16-22 06:52AM
Nov-09-22 08:02AM
Nov-07-22 05:55PM
04:06PM
04:05PM
Oct-26-22 07:54AM
Oct-25-22 04:03PM
Oct-20-22 04:03PM
Oct-10-22 11:31AM
Aug-26-22 07:22AM
Aug-25-22 12:10PM
Aug-23-22 02:03PM
Aug-06-22 05:00AM
Aug-05-22 06:30AM
Aug-04-22 07:25PM
04:05PM
08:00AM
08:00AM
Jul-25-22 06:15PM
Jul-19-22 08:00AM
Jul-14-22 06:17PM
Jul-11-22 09:46AM
Jul-05-22 08:00AM
Jun-29-22 06:15PM
Jun-21-22 06:15PM
Jun-19-22 09:06AM
Jun-04-22 08:06AM
May-19-22 07:04AM
May-17-22 11:30AM
May-03-22 11:30PM
05:25PM
04:05PM
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Xie Jian President and COO Dec 11 '23 Sale 26.52 22,000 583,453 363,124 Dec 13 08:49 PM Xie Jian President and COO Dec 04 '23 Sale 27.57 1,779 49,053 385,124 Dec 06 06:00 PM Gao Hanlin Chief Scientific Officer Dec 04 '23 Sale 27.57 1,437 39,623 905,882 Dec 06 05:47 PM Kim Paul CFO and Treasurer Dec 04 '23 Sale 27.57 1,437 39,623 200,460 Dec 06 05:54 PM Xie Jian President and COO Nov 16 '23 Sale 27.25 1,617 44,065 386,903 Nov 20 04:30 PM Kim Paul CFO and Treasurer Nov 16 '23 Sale 27.25 1,307 35,617 201,897 Nov 20 04:27 PM Xie Jian President and COO Sep 07 '23 Sale 31.41 1,492 46,861 416,022 Sep 11 04:37 PM Kim Paul CFO and Treasurer Sep 07 '23 Sale 31.41 1,492 46,861 214,061 Sep 11 04:35 PM Gao Hanlin Chief Scientific Officer Sep 07 '23 Sale 31.41 1,041 32,696 912,932 Sep 11 04:34 PM Kim Paul CFO and Treasurer Aug 28 '23 Sale 33.62 10,299 346,297 215,553 Aug 30 04:54 PM Kim Paul CFO and Treasurer Aug 17 '23 Sale 33.88 1,798 60,918 225,852 Aug 21 04:40 PM Xie Jian President and COO Aug 17 '23 Sale 33.88 1,307 44,283 417,514 Aug 21 04:43 PM Gao Hanlin Chief Scientific Officer Aug 17 '23 Sale 33.88 342 11,587 913,973 Aug 21 04:34 PM Xie Jian President and COO Jun 02 '23 Sale 40.30 1,433 57,744 425,794 Jun 06 05:11 PM Kim Paul CFO and Treasurer Jun 02 '23 Sale 40.30 1,403 56,535 228,890 Jun 06 05:09 PM Gao Hanlin Chief Scientific Officer Jun 02 '23 Sale 40.30 1,000 40,296 914,391 Jun 06 05:06 PM Xie Jian President and COO May 17 '23 Sale 35.46 1,320 46,810 427,227 May 19 04:23 PM Kim Paul CFO and Treasurer May 17 '23 Sale 35.46 1,266 44,895 230,293 May 19 04:19 PM Gao Hanlin Chief Scientific Officer May 17 '23 Sale 35.46 345 12,234 915,391 May 19 04:15 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
